http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5716978-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbc3e7608ac2c1394aecf40e0e34b852
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
filingDate 1995-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1943f9e3f764bafa211eba06541a9283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad485ccaa5d677c3f59045bbbafa4c2c
publicationDate 1998-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5716978-A
titleOfInvention Methods of treating circadian rhythm disorders
abstract A method for treating circadian rhythm disorders is described. The method involves the administration of melatonin from about 6 hours to about 19 hours prior to when the normal sleep phase should begin, depending on whether a phase advance shift in circadian rhythms or a phase delay shift is desired. This is typically from about 4 hours to about 17 hours prior to the time of endogenous melatonin onset.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6669627-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004044064-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009011015-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004249237-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008016911-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006165786-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008058405-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7914826-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007264337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7906154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6135117-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008016911-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007196348-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7476405-B2
priorityDate 1990-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5163426-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9407487-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4687763-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4600723-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5167228-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4665086-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0126630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5176133-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127776308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226518246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127440056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129678480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466

Total number of triples: 54.